Tectonic Therapeutic To Present on May 15th, 2025 at the Bank of America Securities Health Care Conference
Tectonic Therapeutic (NASDAQ: TECX), a clinical stage biotech company specializing in therapeutic proteins and antibodies for GPCR modulation, has announced its participation in the Bank of America Securities 2025 Health Care Conference in Las Vegas.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tectonic Therapeutic (NASDAQ: TECX), a clinical stage biotech company specializing in therapeutic proteins and antibodies for GPCR modulation, has announced its participation in the Bank of America Securities 2025 Health Care Conference in Las Vegas. Dr. Alise Reicin, President and CEO, will deliver a corporate presentation on Thursday, May 15th, 2025, at 9:20am PDT.
The management team will be available for one-on-one meetings with investors during the conference. A live webcast will be accessible through the company's website, with a replay available for approximately 90 days after the event.
Details
News Market Reaction – TECX
The recorded move for TECX in the trading session of this news was +0.26%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (“GPCRs”), today announced that Alise Reicin, MD, President and Chief Executive Officer, will present at the Bank of America Securities 2025 Health Care Conference taking place in Las Vegas on May 12-15, 2025.
Bank of America Securities Health Care Conference
| Date: | Thursday, May 15th, 2025 |
| Time: | 9:20am PDT |
| Format: | Corporate Presentation |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The Tectonic management team will host one-on-one meetings at the conference. Interested investors should contact their Bank of America Securities representative to schedule meetings.
The live webcast can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the conference has concluded, a replay of the webcast will be available on the Company’s website for approximately 90 days.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.
Investors: Dan Ferry LifeSci Advisors daniel@lifesciadvisors.com (617) 430-7576 Media: Kathryn Morris The Yates Network kathryn@theyatesnetwork.com (914) 204-6412
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.